Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0156 EUR | -4,29% | -20,41% | -74,51% |
11/04 | BioSenic dient herstructureringsplan in | AM |
20/03 | BioSenic presenteert succesvolle studiedata op het Systemic Sclerosis World Congress 2024 | AM |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 2,86 mln. 3,06 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -5 mln. -5,35 mln. | Nettowinst (verlies) 2024 * | -11 mln. -11,76 mln. | EV/omzet 2023 * | - |
Nettoschuld 2023 * | 18,8 mln. 20,1 mln. | Nettoschuld 2024 * | 29,3 mln. 31,33 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,31
x | K/w-verhouding 2024 * |
-0,17
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 73,22% |
1 dag | -4,29% | ||
1 week | -20,41% | ||
Lopende maand | -29,09% | ||
1 maand | -29,09% | ||
3 maanden | -61,00% | ||
6 maanden | -70,11% | ||
Lopend jaar | -74,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 03-04-23 |
Nicco Carole
COO | Chief Operating Officer | - | 18-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,0156 | -4,29% | 880 789 |
25-04-24 | 0,0163 | +1,87% | 4 023 059 |
24-04-24 | 0,016 | -18,37% | 5 497 888 |
23-04-24 | 0,0196 | -4,85% | 1 075 815 |
22-04-24 | 0,0206 | +5,10% | 1 538 483 |
Real Time Euronext Bruxelles, 26 april 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-74,51% | 3,06 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |